URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=E...
Submission: On November 08 via api from US — Scanned from DE

Summary

This website contacted 33 IPs in 5 countries across 28 domains to perform 79 HTTP transactions. The main IP is 52.0.44.193, located in Ashburn, United States and belongs to AMAZON-AES, US. The main domain is eyewire.news.
TLS certificate: Issued by R3 on September 14th 2021. Valid for: 3 months.
This is the only time eyewire.news was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
22 52.0.44.193 14618 (AMAZON-AES)
5 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 3.220.15.29 14618 (AMAZON-AES)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
6 2606:4700::68... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 143.204.98.29 16509 (AMAZON-02)
3 35.201.103.212 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
3 142.250.186.130 15169 (GOOGLE)
1 143.204.98.33 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 107.178.240.224 15169 (GOOGLE)
1 2600:9000:215... 16509 (AMAZON-02)
1 143.204.98.32 16509 (AMAZON-02)
1 34.254.124.164 16509 (AMAZON-02)
1 151.101.66.217 54113 (FASTLY)
2 2a03:2880:f01... 32934 (FACEBOOK)
7 11 34.250.84.130 16509 (AMAZON-02)
4 2a03:2880:f11... 32934 (FACEBOOK)
3 5 185.33.221.50 29990 (ASN-APPNEX)
1 104.244.42.131 13414 (TWITTER)
1 1 104.75.88.126 16625 (AKAMAI-AS)
1 54.242.174.54 14618 (AMAZON-AES)
1 2 18.156.0.31 16509 (AMAZON-02)
1 2 34.98.64.218 15169 (GOOGLE)
1 69.173.144.165 26667 (RUBICONPR...)
1 1 142.250.181.226 15169 (GOOGLE)
79 33
Apex Domain
Subdomains
Transfer
22 eyewire.news
eyewire.news
102 KB
12 prfct.co
pixel-geo.prfct.co
pixel.prfct.co
5 KB
6 cloudflare.com
cdnjs.cloudflare.com
47 KB
6 typekit.net
use.typekit.net
p.typekit.net
122 KB
5 adnxs.com
secure.adnxs.com
5 KB
5 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
cm.g.doubleclick.net
119 KB
4 facebook.com
www.facebook.com
662 B
4 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
in.hotjar.com
63 KB
3 scaredsidewalk.com
scaredsidewalk.com
31 KB
2 openx.net
us-u.openx.net
473 B
2 yahoo.com
ups.analytics.yahoo.com
572 B
2 facebook.net
connect.facebook.net
113 KB
2 marketingautomation.services
koi-3qnoybpdqq.marketingautomation.services
6 KB
2 google-analytics.com
www.google-analytics.com
20 KB
2 google.com
www.google.com
adservice.google.com
1 KB
1 rubiconproject.com
pixel.rubiconproject.com
239 B
1 addthis.com
cw.addthis.com
451 B
1 twitter.com
analytics.twitter.com
598 B
1 perfectaudience.com
tag.perfectaudience.com
4 KB
1 adsafeprotected.com
static.adsafeprotected.com
480 B
1 googlesyndication.com
0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com
4 KB
1 google.de
adservice.google.de
792 B
1 gstatic.com
www.gstatic.com
136 KB
1 hs-analytics.net
js.hs-analytics.net
20 KB
1 bmctoday.net
core4.bmctoday.net
3 MB
1 googletagmanager.com
www.googletagmanager.com
36 KB
1 googletagservices.com
www.googletagservices.com
27 KB
0 piwik.pro Failed
bmcanalytics.piwik.pro Failed
bmcanalytics.containers.piwik.pro Failed
79 28
Domain Requested by
22 eyewire.news eyewire.news
11 pixel-geo.prfct.co 7 redirects eyewire.news
6 cdnjs.cloudflare.com eyewire.news
5 secure.adnxs.com 3 redirects eyewire.news
5 use.typekit.net eyewire.news
use.typekit.net
4 www.facebook.com eyewire.news
3 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
3 scaredsidewalk.com eyewire.news
scaredsidewalk.com
2 us-u.openx.net 1 redirects eyewire.news
2 ups.analytics.yahoo.com 1 redirects eyewire.news
2 connect.facebook.net tag.perfectaudience.com
connect.facebook.net
2 koi-3qnoybpdqq.marketingautomation.services eyewire.news
koi-3qnoybpdqq.marketingautomation.services
2 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
1 cm.g.doubleclick.net 1 redirects
1 pixel.rubiconproject.com eyewire.news
1 pixel.prfct.co eyewire.news
1 cw.addthis.com 1 redirects
1 analytics.twitter.com eyewire.news
1 tag.perfectaudience.com koi-3qnoybpdqq.marketingautomation.services
1 in.hotjar.com script.hotjar.com
1 vars.hotjar.com static.hotjar.com
1 static.adsafeprotected.com eyewire.news
1 stats.g.doubleclick.net www.google-analytics.com
1 0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 adservice.google.com securepubads.g.doubleclick.net
1 adservice.google.de securepubads.g.doubleclick.net
1 script.hotjar.com static.hotjar.com
1 www.gstatic.com www.google.com
1 static.hotjar.com eyewire.news
1 js.hs-analytics.net eyewire.news
1 www.google.com eyewire.news
1 p.typekit.net use.typekit.net
1 core4.bmctoday.net eyewire.news
1 www.googletagmanager.com eyewire.news
1 www.googletagservices.com eyewire.news
0 bmcanalytics.containers.piwik.pro Failed eyewire.news
0 bmcanalytics.piwik.pro Failed eyewire.news
79 37
Subject Issuer Validity Valid
eyewire.news
R3
2021-09-14 -
2021-12-13
3 months crt.sh
use.typekit.net
DigiCert TLS RSA SHA256 2020 CA1
2021-08-16 -
2022-08-16
a year crt.sh
*.g.doubleclick.net
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
core4.bmctoday.net
R3
2021-10-08 -
2022-01-06
3 months crt.sh
*.typekit.net
DigiCert TLS RSA SHA256 2020 CA1
2021-07-16 -
2022-07-21
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-09-21 -
2022-09-20
a year crt.sh
www.google.com
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
*.hotjar.com
Amazon
2020-12-25 -
2022-01-23
a year crt.sh
scaredsidewalk.com
R3
2021-10-23 -
2022-01-21
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
*.google.de
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
*.google.com
GTS CA 1C3
2021-10-18 -
2022-01-10
3 months crt.sh
*.marketingautomation.services
Sectigo RSA Organization Validation Secure Server CA
2020-03-12 -
2022-06-10
2 years crt.sh
static.adsafeprotected.com
Amazon
2021-09-05 -
2022-10-04
a year crt.sh
*.perfectaudience.com
GlobalSign Atlas R3 DV TLS CA 2020
2021-03-22 -
2022-04-23
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2021-08-17 -
2021-11-15
3 months crt.sh
*.prfct.co
DigiCert SHA2 Secure Server CA
2019-09-03 -
2021-10-27
2 years crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2021-03-05 -
2022-02-19
a year crt.sh

This page contains 3 frames:

Primary Page: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Frame ID: 79AE612CCF8024AA08F04D970C0AA3CF
Requests: 77 HTTP requests in this frame

Frame: https://0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: F853A8764E31D0B33C117B1B60F11D50
Requests: 1 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-d09a446edefba0dcce5d5143e1840e9a.html
Frame ID: 49E0E4551EC85704776F5293C04C1438
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

FDA Approves Allergan's Vuity, the First and Only Eye Drop to Treat Presbyopia - Eyewire+twitter-sharefacebook-sharelinkedin-shareemail-shareemailemailtwitter-sharefacebook-sharelinkedin-shareinstagram-sharetwitter-sharefacebook-sharelinkedin-shareinstagram-share

Page Statistics

79
Requests

85 %
HTTPS

44 %
IPv6

28
Domains

37
Subdomains

33
IPs

5
Countries

3825 kB
Transfer

5334 kB
Size

32
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 60
  • https://pixel-geo.prfct.co/tagjs?a_id=159839&source=js_tag HTTP 302
  • https://pixel-geo.prfct.co/tagjs?check_cookie=1&a_id=159839&source=js_tag
Request Chain 63
  • https://secure.adnxs.com/getuid?https://pixel-geo.prfct.co/usermap/?xid=$UID&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ HTTP 307
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fpixel-geo.prfct.co%2Fusermap%2F%3Fxid%3D%24UID%26sid%3D202111%7C61892d7cb663f107323cd788%26pid%3Dpa_UGsQ1ydO4z3X3wPpJ HTTP 302
  • https://pixel-geo.prfct.co/usermap/?xid=4541810686184272198&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ
Request Chain 64
  • https://pixel-geo.prfct.co/cs/?partnerId=twtr HTTP 302
  • https://analytics.twitter.com/i/adsct?p_id=48571&p_user_id=pa_UGsQ1ydO4z3X3wPpJ
Request Chain 65
  • https://pixel-geo.prfct.co/cs/?partnerId=crw HTTP 302
  • https://cw.addthis.com/t.gif?pid=37&pidt=0&pdid=pa_UGsQ1ydO4z3X3wPpJ&cu=https%3A%2F%2Fpixel.prfct.co%2Fcb%3FpartnerId%3Dcrw HTTP 302
  • https://pixel.prfct.co/cb?partnerId=crw
Request Chain 66
  • https://pixel-geo.prfct.co/cs/?partnerId=yah HTTP 302
  • https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1 HTTP 302
  • https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1&verify=true
Request Chain 67
  • https://pixel-geo.prfct.co/cs/?partnerId=opx HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ HTTP 302
  • https://us-u.openx.net/w/1.0/sd?cc=1&id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ
Request Chain 68
  • https://pixel-geo.prfct.co/cs/?partnerId=rbcn HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=189868&nid=4106&expires=30&put=pa_UGsQ1ydO4z3X3wPpJ
Request Chain 69
  • https://pixel-geo.prfct.co/cs/?partnerId=goo HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=nowspots_bidder&google_hm=cGFfVUdzUTF5ZE80ejNYM3dQcEo HTTP 302
  • https://pixel-geo.prfct.co/cb?partnerId=goo
Request Chain 72
  • https://secure.adnxs.com/seg?t=2&add=26756226 HTTP 307
  • https://secure.adnxs.com/bounce?%2Fseg%3Ft%3D2%26add%3D26756226

79 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia
eyewire.news/news/
86 KB
18 KB
Document
General
Full URL
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
286ced3f47dcdcc61920c6cad37d2168b92c4edd9a47eb0b647d998fa5cfe201

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Accept-Language
de-DE,de;q=0.9

Response headers

Date
Mon, 08 Nov 2021 14:00:26 GMT
Server
Apache/2.4.51 (Ubuntu)
Cache-Control
no-cache, private, max-age=31536000
Expires
Tue, 08 Nov 2022 14:00:26 GMT
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
17587
Keep-Alive
timeout=5, max=100
Connection
Keep-Alive
Content-Type
text/html; charset=UTF-8
fab2ivl.css
use.typekit.net/
4 KB
1 KB
Stylesheet
General
Full URL
https://use.typekit.net/fab2ivl.css
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:ba0a Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
b39b617c63e4f29f1a677c2f350c3c9b14ac8455d721c26b90eb034a0933e00f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains;
content-encoding
gzip
server
nginx
date
Mon, 08 Nov 2021 14:00:26 GMT
vary
Accept-Encoding
content-type
text/css;charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=600, stale-while-revalidate=604800
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
795
jquery.fancybox.min.css
eyewire.news/css/
12 KB
3 KB
Stylesheet
General
Full URL
https://eyewire.news/css/jquery.fancybox.min.css
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
5736e3eec0c34bfc288854b7b8d2a8f1e22e9e2e7dae3c8d1ad5dfb2d4734ad0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"31fb-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
3096
Expires
Tue, 08 Nov 2022 14:00:27 GMT
flickity.min.css
eyewire.news/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://eyewire.news/css/flickity.min.css
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
458c60eed8899cb810aba300f7b68f3b2f900add77eb41b93ec0a6897c3cedd0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"741-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=98
Content-Length
644
Expires
Tue, 08 Nov 2022 14:00:27 GMT
bootstrap.min.css
eyewire.news/css/
16 KB
4 KB
Stylesheet
General
Full URL
https://eyewire.news/css/bootstrap.min.css
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
d99ad77f8f1e1522b88c21422bfb4f602e10d5e0f820e7774ff4f80add7f432a

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"3e46-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
3481
Expires
Tue, 08 Nov 2022 14:00:27 GMT
main.css
eyewire.news/css/
134 KB
19 KB
Stylesheet
General
Full URL
https://eyewire.news/css/main.css
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
b69dcd0486530c313a1771d1d922ca2834ea0c43a06c7da87ed26937c80b2883

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"217d9-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
text/css
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
19307
Expires
Tue, 08 Nov 2022 14:00:27 GMT
gpt.js
www.googletagservices.com/tag/js/
79 KB
27 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
12ccf827ffd5452b891e6219a9d3be8222aea9ab9d2277bfb9cf06e745dc2159
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1037 / 280 of 1000 / last-modified: 1636373146"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27113
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Mon, 08 Nov 2021 14:00:27 GMT
js
www.googletagmanager.com/gtag/
90 KB
36 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=UA-11843436-1
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
dc910bfbe23f33ed76920d826ef313c59e9dec1cea0d41cc899448231da5ae91
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
36346
x-xss-protection
0
last-modified
Mon, 08 Nov 2021 12:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Mon, 08 Nov 2021 14:00:27 GMT
Eyewire-Plus-Logo.png
eyewire.news/img/logos/
3 KB
4 KB
Image
General
Full URL
https://eyewire.news/img/logos/Eyewire-Plus-Logo.png
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
f1e058418cedc72dc4488f8d4d13a6a385f2b4c1c2d92348106065c884aa0afd

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"d8e-5cfd47e07a580"
Content-Type
image/png
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=98
Content-Length
3470
Expires
Tue, 08 Nov 2022 14:00:27 GMT
open-close.svg
eyewire.news/img/icons/
624 B
985 B
Image
General
Full URL
https://eyewire.news/img/icons/open-close.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
1a6aa1721fd3fbd15c8b690d917e5cce3c49face35cdfbc33c3b9364453e11a7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"270-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
624
Expires
Tue, 08 Nov 2022 14:00:27 GMT
search-s.svg
eyewire.news/img/icons/
1 KB
2 KB
Image
General
Full URL
https://eyewire.news/img/icons/search-s.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
00045ced31b0162f718bb52d24da80957ee91ceea8ef42b770f553f04889ec7f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"49b-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
1179
Expires
Tue, 08 Nov 2022 14:00:27 GMT
close.png
eyewire.news/img/
399 B
756 B
Image
General
Full URL
https://eyewire.news/img/close.png
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
f0734491d9e30ab4f2fd976ba4cda6ba071154f24ea8fcd53147618d03338453

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"18f-5cfd47e07a580"
Content-Type
image/png
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
399
Expires
Tue, 08 Nov 2022 14:00:27 GMT
share-open.svg
eyewire.news/img/icons/
2 KB
2 KB
Image
General
Full URL
https://eyewire.news/img/icons/share-open.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
f1e84c405eccf9a1d2ebd78fce644908057170b525733a83e326fc27893ff7c1

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"6be-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
1726
Expires
Tue, 08 Nov 2022 14:00:27 GMT
link-copy.svg
eyewire.news/img/icons/
2 KB
3 KB
Image
General
Full URL
https://eyewire.news/img/icons/link-copy.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
a366cc8c38cafb91d8cf5036bef52832d397236001bcefcbb214b25fbeed4425

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"910-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=96
Content-Length
2320
Expires
Tue, 08 Nov 2022 14:00:27 GMT
11597815c35_R0_SmAngledBox_Bottle_1635604008.jpg
core4.bmctoday.net/storage/images/
3 MB
3 MB
Image
General
Full URL
https://core4.bmctoday.net/storage/images/11597815c35_R0_SmAngledBox_Bottle_1635604008.jpg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
3.220.15.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-220-15-29.compute-1.amazonaws.com
Software
Apache/2.4.29 (Ubuntu) /
Resource Hash
b0df3444c55338c1de6e7e21c438a8073dc196273914d39958c2a43ce73ee45c

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Sat, 30 Oct 2021 14:26:48 GMT
Server
Apache/2.4.29 (Ubuntu)
ETag
"2e62c6-5cf92bbee1f41"
Content-Type
image/jpeg
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
3039942
p.css
p.typekit.net/
5 B
162 B
Stylesheet
General
Full URL
https://p.typekit.net/p.css?s=1&k=fab2ivl&ht=tk&f=13474.17265.17267.17268.17269&a=4272290&app=typekit&e=css
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/fab2ivl.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:28d::19fd Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
1c0ff118a4290c99f39c90abb38703a866e47251b23cca20266c69c812ccafeb

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://use.typekit.net/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:26 GMT
last-modified
Thu, 05 Nov 2020 13:49:42 GMT
server
nginx
etag
"5fa402f6-5"
content-type
text/css
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
content-length
5
right-arrow.svg
eyewire.news/img/icons/
665 B
1 KB
Image
General
Full URL
https://eyewire.news/img/icons/right-arrow.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
e9002760a6df7b501d46f07c7d78968e079bed312d00469585eb0a52b062c5f3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"299-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
665
Expires
Tue, 08 Nov 2022 14:00:27 GMT
Eyewire-Plus-BMC-Lockup.png
eyewire.news/img/logos/
4 KB
5 KB
Image
General
Full URL
https://eyewire.news/img/logos/Eyewire-Plus-BMC-Lockup.png
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
84fb2b6f8ec189ce3220b7cca5f41270ef74ad294fc0f5267b57c32dcda90001

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"1146-5cfd47e07a580"
Content-Type
image/png
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=96
Content-Length
4422
Expires
Tue, 08 Nov 2022 14:00:27 GMT
one-trust-button.png
eyewire.news/img/assorted/
5 KB
5 KB
Image
General
Full URL
https://eyewire.news/img/assorted/one-trust-button.png
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
4d17c46f372f4e8422d6beba41042db9a7211562d921fb16c0a2c663e7e6891e

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"139f-5cfd47e07a580"
Content-Type
image/png
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=96
Content-Length
5023
Expires
Tue, 08 Nov 2022 14:00:27 GMT
jquery.min.js
cdnjs.cloudflare.com/ajax/libs/jquery/3.6.0/
87 KB
28 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/jquery/3.6.0/jquery.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Referer
https://eyewire.news/
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
403268
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
27938
timing-allow-origin
*
last-modified
Tue, 02 Mar 2021 18:58:36 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"603e8adc-15d9d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=LccqgjwOhSRrR2lmbduBJIwyjsbqlWzr1tyw9XMSjN5yKH7bWKIzD59p4Q4vpoPsTRNeZU4%2BtNsRXygZVPQNkBSVi4Qflov%2Fr0aTy6DRUvVyaUn7cUzLrRwntFRHufwkOxFdvPvNOBe6vWuXRELSw%2F0%2B"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e2f80c6931-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
lazyload.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/17.3.1/
7 KB
3 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/17.3.1/lazyload.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e6a23e6a3399b52a5576c28b2236b48953949793fc17f2c733d35b084d7a0085
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Referer
https://eyewire.news/
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
3436018
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
2365
timing-allow-origin
*
last-modified
Sun, 07 Feb 2021 21:15:59 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"6020588f-1d61"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=akX%2FSJFU9RE6Vo4cDM4Q%2BL%2Fha9%2BBy2fZWbViKcBONiBDxUjx11RGp6DNC2rkouUkjqpgSg7HphUbbklSPB%2BM5GVTc9XpUkD3q%2BwfHphfKXUHPCS%2BJ4VXCC%2FE1izgLFzWvNyklHz3ZOPWy99xtv54MOKL"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e328ad6931-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
modernizr.min.js
cdnjs.cloudflare.com/ajax/libs/modernizr/2.7.1/
14 KB
6 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/modernizr/2.7.1/modernizr.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0b2a741489fb323cd96e2b546693ca1fc7151cfa0f2111eee4dd512e6b359941
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
3436947
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
5231
timing-allow-origin
*
last-modified
Mon, 04 May 2020 16:13:26 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"5eb03f26-38fa"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1VhMoZVqynIIlymDi16EYBn7f751mHVPSL%2Bn0mnDl52Co14EuGmm2c37xEAqcrHaY4DtLVLPZosQziPeYcmemlsJHQO7MVuW%2F7h0rWJfY%2BSmaCjB5Nh%2Beh7JCwKnHPqW1IJ4Pwq5blvoBZ5G7RtxRMVd"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e36e3f6997-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
api.js
www.google.com/recaptcha/
850 B
969 B
Script
General
Full URL
https://www.google.com/recaptcha/api.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
9b80d81bcdcba7b6f787cad8c103d520eb4b68ce9299abd52195c99f6c100900
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
content-security-policy
frame-ancestors 'self'
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
556
x-xss-protection
1; mode=block
expires
Mon, 08 Nov 2021 14:00:27 GMT
js.cookie-2.2.0.min.js
eyewire.news/js/
2 KB
1 KB
Script
General
Full URL
https://eyewire.news/js/js.cookie-2.2.0.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
3202ba1cb0ab2ebf8eeb0caebf6fa6ba681b5575c48b2f314f345d82eedaaac2

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"6b0-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
897
Expires
Tue, 08 Nov 2022 14:00:27 GMT
jquery.actual.min.js
eyewire.news/js/
1 KB
1 KB
Script
General
Full URL
https://eyewire.news/js/jquery.actual.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
1b134d750801cede012084b0fe5384264f95aec96b9be9dbf5cf7a42dff81117

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"4d7-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=99
Content-Length
685
Expires
Tue, 08 Nov 2022 14:00:27 GMT
jquery.fancybox.min.js
eyewire.news/js/
67 KB
22 KB
Script
General
Full URL
https://eyewire.news/js/jquery.fancybox.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
cadda460ccb4c3c01bb45f3d5976f63f5adf8dc3ff1d31cb4fbd3ded4f18e5bf

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"10a9d-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=97
Content-Length
22013
Expires
Tue, 08 Nov 2022 14:00:27 GMT
jquery.validate.min.js
cdnjs.cloudflare.com/ajax/libs/jquery-validate/1.19.3/
24 KB
7 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/jquery-validate/1.19.3/jquery.validate.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4c0cc637858d6503cba9262f8be75740c29e853605a153a7bde46a6e2e367eb0
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
1630471
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
6996
timing-allow-origin
*
last-modified
Fri, 11 Jun 2021 11:01:59 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"60c342a7-1b54"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=a3Gn6%2FevkqP0lasrpZI73bFFaT78DIxjgjg2D0M9i6QtNW3Uq%2F8Xs42Oy99K3TByVUospRnH9WEqyoB6vLfdSsWKgMSPYh3X%2FQNIeeGPx%2FoYH7cIsV66a4OOzaAq0%2FzuVk44MfM3kjT9GzhQhDhGZPof"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e3cf296997-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
tinysort.min.js
cdnjs.cloudflare.com/ajax/libs/tinysort/3.2.5/
4 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/tinysort/3.2.5/tinysort.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5fccf4b8b64dec989d6295cf25e3af5dbc7a5ba965875ff07f0eff9c98ed4def
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Referer
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
2747571
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
1910
timing-allow-origin
*
last-modified
Mon, 04 May 2020 16:17:02 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"5eb03ffe-10d2"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=91r08rSmJxSzCNauw42E5DL05i5N9Uen8Jrvp6PrKPTdmJfGVDw0%2FFXSIRGbaPBi8PkbfaH20UnScYCBcU49SbeX6Fak0RLLI9ra%2FlPAALF434xn6lNlNiLpRjrW3M9DTVeiyIXxm8DQ%2Ba3a%2B3SgzP2V"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e3ca736931-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
jquery.tinysort.min.js
cdnjs.cloudflare.com/ajax/libs/tinysort/3.2.5/
570 B
617 B
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/tinysort/3.2.5/jquery.tinysort.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:135e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
633a5afd1cc1ff46c78c44457e92969f185435e741a304ed822e63101ab7b142
Security Headers
Name Value
Strict-Transport-Security max-age=15780000
X-Content-Type-Options nosniff

Request headers

Referer
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
age
984674
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
content-length
278
timing-allow-origin
*
last-modified
Mon, 04 May 2020 16:17:02 GMT
server
cloudflare
cf-cdnjs-via
cfworker/kv
etag
"5eb03ffe-23a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=MKyLiJ%2Ft%2Bt6MMP1cXiaJt5iJfrqHw5Qjr5PCTGw2o41X2VzcRUW1Xk2n5OyheLspFTs08kgEyCerI4DrlQ8xOjXVcKZ1dXVg2ddC8aZTaTXs4kJtqEwnBgw%2BP5mnAgYFXCpK95MY1KG5xk652vWJgNvy"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=30672000
accept-ranges
bytes
cf-ray
6aaf53e3ca766931-FRA
expires
Sat, 29 Oct 2022 14:00:27 GMT
adframe.js
eyewire.news/_core4/js/
16 B
385 B
Script
General
Full URL
https://eyewire.news/_core4/js/adframe.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
0059cb4ff0a271382c38af8a7367aaf45cbeb31449637d3928d25317401e2828

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:57:45 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"10-5cfd48b998d5e"
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=100
Content-Length
16
Expires
Tue, 08 Nov 2022 14:00:27 GMT
core4.js
eyewire.news/_core4/js/
7 KB
2 KB
Script
General
Full URL
https://eyewire.news/_core4/js/core4.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
d75dfc1b59df3c317def1bc9c540072146ed8f177f18303f9f20af5fdc733bad

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:57:45 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"1c45-5cfd48b998d5e-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=97
Content-Length
1358
Expires
Tue, 08 Nov 2022 14:00:27 GMT
lazyload.min.js
eyewire.news/_core4/js/
7 KB
3 KB
Script
General
Full URL
https://eyewire.news/_core4/js/lazyload.min.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
c94b350d90e850fefdbfc5d9498770dac371f18876191821eec42c0bfc69484d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:57:45 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"1d60-5cfd48b998d5e-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=97
Content-Length
2680
Expires
Tue, 08 Nov 2022 14:00:27 GMT
main.js
eyewire.news/js/
9 KB
3 KB
Script
General
Full URL
https://eyewire.news/js/main.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
f02754021c8618177ed0b2b5926c7015e0f30f5efb97924bb08a6ad6dba97fb2

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"23b5-5cfd47e07a580-gzip"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=95
Content-Length
2573
Expires
Tue, 08 Nov 2022 14:00:27 GMT
2022187.js
js.hs-analytics.net/analytics/1636380300000/
63 KB
20 KB
Script
General
Full URL
https://js.hs-analytics.net/analytics/1636380300000/2022187.js
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:45b0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6293352639977ab51c2987a9bea83dd580c3d61f69c82900193971aa2441ed71

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
cf-cache-status
HIT
age
27
x-amz-server-side-encryption
AES256
x-amz-request-id
N8CRY6FZ65HSMPA6
x-amz-id-2
OjFLXUrnEivTE3QxxDty0fwmMp7TjalW8mLtbplR1W+JdbmA2p1b6poSSVpZvL86YxPvX9CL5Pk=
last-modified
Mon, 19 Jul 2021 14:19:13 GMT
server
cloudflare
etag
W/"6cfbb937ac645ffd537f09d9c0344307"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=300, public
access-control-allow-credentials
false
x-amz-version-id
null
cf-ray
6aaf53e42a951f29-FRA
expires
Mon, 08 Nov 2021 14:05:00 GMT
hotjar-677752.js
static.hotjar.com/c/
4 KB
2 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-677752.js?sv=6
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.29 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-29.fra50.r.cloudfront.net
Software
/
Resource Hash
4a8b1688e8561642448dee7970e986fc086115d5fcda360c0ba44c14e030422e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
cache-control
max-age=60
x-amz-cf-pop
FRA50-C1
etag
W/b3a97b0f6f22bc242524000eaf8a6234
vary
Accept-Encoding
x-cache
RefreshHit from cloudfront
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
x-cache-hit
1
content-length
2035
via
1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
x-amz-cf-id
SewgjtChDy3T7BTBaBrL9UPYF_H-dwnklyj5RWP_17NMkDKxRZVnKA==
v2yzgyC3XvHkuj_di8jp-6Su0yVIVtrebnqdUhIXMYKmrbLPMFJ6pTxmDmUrPxMWqJA
scaredsidewalk.com/
103 KB
30 KB
Script
General
Full URL
https://scaredsidewalk.com/v2yzgyC3XvHkuj_di8jp-6Su0yVIVtrebnqdUhIXMYKmrbLPMFJ6pTxmDmUrPxMWqJA
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.103.212 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
212.103.201.35.bc.googleusercontent.com
Software
/
Resource Hash
f706548f1b92012cc9c1973b2974b0577f91e8d42befd50b570dbe1ae1f2dec7
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; preload

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

strict-transport-security
max-age=15724800; preload
content-encoding
br
x-datacenter
gce-europe-west1
etag
"39ca409d13f4cdedb6eeb94070e94f54b851e3e7a9b329760eb904e9a5055dac"
vary
Accept-Encoding, Accept-Language
x-hostname
0f8346e1
content-type
text/javascript; charset=utf-8
cache-control
private, must-revalidate, max-age=21600
date
Mon, 08 Nov 2021 14:00:27 GMT
timing-allow-origin
*
audience-manager.api.min.js
bmcanalytics.piwik.pro/audiences/static/widget/
0
0

3aa8057d-9500-485f-a9f4-c346e81304ac.js
bmcanalytics.containers.piwik.pro/
0
0

search-glass.svg
eyewire.news/img/icons/
1 KB
2 KB
Image
General
Full URL
https://eyewire.news/img/icons/search-glass.svg
Requested by
Host: eyewire.news
URL: https://eyewire.news/css/main.css
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.0.44.193 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-0-44-193.compute-1.amazonaws.com
Software
Apache/2.4.51 (Ubuntu) /
Resource Hash
6dc1785f7aee2d82fc98964068452483b6d76c5f2e1671081a0ebc5b88df7558

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/css/main.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Date
Mon, 08 Nov 2021 14:00:27 GMT
Last-Modified
Tue, 02 Nov 2021 20:53:58 GMT
Server
Apache/2.4.51 (Ubuntu)
ETag
"49f-5cfd47e07a580"
Content-Type
image/svg+xml
Cache-Control
max-age=31536000
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=5, max=98
Content-Length
1183
Expires
Tue, 08 Nov 2022 14:00:27 GMT
l
use.typekit.net/af/ffb1e2/00000000000000003b9b3d64/27/
28 KB
28 KB
Font
General
Full URL
https://use.typekit.net/af/ffb1e2/00000000000000003b9b3d64/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/fab2ivl.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:ba0a Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
5efc5dfd683b93e41cf5c563bd121060d7d6e79fb85cea91fdcdd2390fbd870f

Request headers

Referer
https://use.typekit.net/fab2ivl.css
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
server
nginx
etag
"5cd645e6a581dd931c7039df4868b37bf0abdeb2"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
28392
l
use.typekit.net/af/80e9a7/000000000000000077359fce/30/
25 KB
25 KB
Font
General
Full URL
https://use.typekit.net/af/80e9a7/000000000000000077359fce/30/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n9&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/fab2ivl.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:ba0a Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
d35c881fea16d4971f529ebb5690448817d1ccb91d394890298e81e5c50858a5

Request headers

Referer
https://use.typekit.net/fab2ivl.css
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
server
nginx
etag
"bbf7625a3531fca0e836b44d63cae8f1b41d60eb"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
25104
l
use.typekit.net/af/422d60/00000000000000003b9b3d67/27/
33 KB
34 KB
Font
General
Full URL
https://use.typekit.net/af/422d60/00000000000000003b9b3d67/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/fab2ivl.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:ba0a Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
c25b5762336d9578b4e7497e5688ceae44a63b30bfa77a9ea03cce10ed2e912e

Request headers

Referer
https://use.typekit.net/fab2ivl.css
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
server
nginx
etag
"4e6bbf222d840839472a8449ffe23ff5d61836c0"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
34220
l
use.typekit.net/af/61f808/00000000000000003b9b3d63/27/
34 KB
34 KB
Font
General
Full URL
https://use.typekit.net/af/61f808/00000000000000003b9b3d63/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/fab2ivl.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:ba0a Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
nginx /
Resource Hash
8c8bd8d99b05c8348e32644b8e25cc70efce41c396b5958727178611856c6c2c

Request headers

Referer
https://use.typekit.net/fab2ivl.css
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
server
nginx
etag
"ac5f07169afed1f853206bdc2309dfaf2c118db1"
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
34560
recaptcha__de.js
www.gstatic.com/recaptcha/releases/kcXVPRWG7fMILHmzon0--fD3/
346 KB
136 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/kcXVPRWG7fMILHmzon0--fD3/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
519f71e8a6cac156c0290fb5b79372191890e23d46a94cbe3a744e6470f074c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://eyewire.news/
Origin
https://eyewire.news
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 13:52:28 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
479
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
138756
x-xss-protection
0
last-modified
Mon, 01 Nov 2021 18:13:57 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin-allow-popups; report-to="recaptcha"
expires
Tue, 08 Nov 2022 13:52:28 GMT
pubads_impl_2021110201.js
securepubads.g.doubleclick.net/gpt/
346 KB
117 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021110201.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s07-in-f2.1e100.net
Software
sffe /
Resource Hash
50ad3a273dd7803066fae0fb2e4eec57cdfb969f449d86309527578d7e08d249
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
118932
x-xss-protection
0
last-modified
Tue, 02 Nov 2021 08:34:31 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Mon, 08 Nov 2021 14:00:27 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
31 B
683 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=eyewire.news
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s07-in-f2.1e100.net
Software
cafe /
Resource Hash
5e245c78f13d392d81ed85a0fbe2518c45ab6d34839856aea4bf2c7402b05994
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
47
x-xss-protection
0
expires
Mon, 08 Nov 2021 14:00:27 GMT
modules.d4630e91cffbd6b56a37.js
script.hotjar.com/
222 KB
59 KB
Script
General
Full URL
https://script.hotjar.com/modules.d4630e91cffbd6b56a37.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-677752.js?sv=6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.33 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-33.fra50.r.cloudfront.net
Software
/
Resource Hash
dd8bce41d0be6d4e5449bef910b493bcf872a4189a361451102996bfe0082f3a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Thu, 28 Oct 2021 10:41:05 GMT
content-encoding
br
x-content-type-options
nosniff
age
962362
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
content-length
59861
access-control-allow-origin
*
last-modified
Thu, 28 Oct 2021 10:40:59 GMT
etag
"fe2e85deda154f5a6e0e0112bec8a18c"
vary
Accept-Encoding
content-type
application/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=31536000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-robots-tag
none
x-amz-cf-id
GkseccWijRsW608I44B-l4kUWhbWoIuirT1z-_qlgWbq1cD5nVO-ng==
analytics.js
www.google-analytics.com/
48 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-11843436-1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
fd222137f245c06ddb4c4d44db41f12138dad6cf8ef5d4d4a5e500f38f0c8c62
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 26 Oct 2021 23:24:02 GMT
server
Golfe2
age
7161
date
Mon, 08 Nov 2021 12:01:06 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19747
expires
Mon, 08 Nov 2021 14:01:06 GMT
integrator.js
adservice.google.de/adsid/
107 B
792 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=eyewire.news
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021110201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
549 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=eyewire.news
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021110201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
892 B
753 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=4047662400756874&correlator=1315988988137739&output=ldjh&impl=fifs&eid=44754276%2C31063246&vrg=2021110201&ptt=17&npa=1&sc=1&sfv=1-0-38&ecs=20211108&iu_parts=169748214%2CBMC%2CEWT%2CROS&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=728x90%2C728x90&cookie_enabled=1&bc=31&abxe=1&lmt=1636380027&dt=1636380027711&dlt=1636380026879&idt=812&frm=20&biw=1600&bih=1200&oid=2&adxs=436%2C436&adys=133%2C1210&adks=4252661532%2C4252661535&ucis=1%7C2&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x90%7C728x-1&msz=728x90%7C728x-1&ga_vid=1452769361.1636380028&ga_sid=1636380028&ga_hid=935412471&ga_fc=false&fws=4%2C516&ohw=1600%2C1600&btvi=0%7C1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIl0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021110201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s07-in-f2.1e100.net
Software
cafe /
Resource Hash
f4dafc81e4277ff73cf3d15c1efa531d0e7c21e26f2ebedc479ac68633647775
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
240
x-xss-protection
0
google-lineitem-id
-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://eyewire.news
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame F853
6 KB
4 KB
Document
General
Full URL
https://0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021110201.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
timing-allow-origin
*
content-length
3108
date
Mon, 08 Nov 2021 14:00:27 GMT
expires
Tue, 08 Nov 2022 14:00:27 GMT
cache-control
public, immutable, max-age=31536000
last-modified
Tue, 02 Mar 2021 20:17:03 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
collect
www.google-analytics.com/j/
2 B
205 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j93&a=935412471&t=pageview&_s=1&dl=https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email&ul=en-us&de=UTF-8&dt=FDA%20Approves%20Allergan%27s%20Vuity%2C%20the%20First%20and%20Only%20Eye%20Drop%20to%20Treat%20Presbyopia%20-%20Eyewire%2B&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YAhAAUABAAAAAC~&jid=376892482&gjid=391897369&cid=1452769361.1636380028&tid=UA-11843436-1&_gid=221109256.1636380028&_r=1&gtm=2oub31&z=1987433683
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://eyewire.news/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 08 Nov 2021 14:00:27 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://eyewire.news
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/j/
1 B
437 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j93&tid=UA-11843436-1&cid=1452769361.1636380028&jid=376892482&gjid=391897369&_gid=221109256.1636380028&_u=YAhAAUAAAAAAAC~&z=54940933
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c03::9c Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://eyewire.news/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Mon, 08 Nov 2021 14:00:27 GMT
content-type
text/plain
access-control-allow-origin
https://eyewire.news
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
ss.js
koi-3qnoybpdqq.marketingautomation.services/client/
12 KB
5 KB
Script
General
Full URL
https://koi-3qnoybpdqq.marketingautomation.services/client/ss.js?ver=2.4.0
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
107.178.240.224 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
224.240.178.107.bc.googleusercontent.com
Software
openresty /
Resource Hash
8c78a51baaafdb60084333cabd9099b2f37278adf882cea7d5de0ef1188c5aa6

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:27 GMT
content-encoding
gzip
last-modified
Fri, 05 Nov 2021 13:33:06 GMT
server
openresty
etag
W/"61853292-2fc1"
vary
Accept-Encoding
content-type
application/javascript
via
1.1 google
cache-control
max-age=604800, public
alt-svc
clear
expires
Mon, 15 Nov 2021 14:00:27 GMT
skeleton.gif
static.adsafeprotected.com/
43 B
480 B
Image
General
Full URL
https://static.adsafeprotected.com/skeleton.gif
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:fa00:8:48e:53c0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
42b976597a2d977d0e300f6d06bc903db389e5c112d33c1c8c249690a522d9f2

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Fri, 06 Aug 2021 16:14:35 GMT
via
1.1 6b8ac2d6d64dc42007741d312e2d73ab.cloudfront.net (CloudFront)
age
8113553
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
content-length
43
last-modified
Mon, 17 Aug 2020 23:55:15 GMT
server
AmazonS3
etag
"45cf913e5d9d3c9b2058033056d3dd23"
x-amz-version-id
iiN8XkcmZQdDIQeKkzAiegPwcD.5WPja
cache-control
max-age=315360000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-type
image/gif
x-amz-cf-id
au5hn5N479nmB2aPvxy961_YqBEc_drzKQY8VPa0tDhZpO1rLXh87w==
box-d09a446edefba0dcce5d5143e1840e9a.html
vars.hotjar.com/ Frame 49E0
2 KB
1 KB
Document
General
Full URL
https://vars.hotjar.com/box-d09a446edefba0dcce5d5143e1840e9a.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-677752.js?sv=6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.32 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-32.fra50.r.cloudfront.net
Software
/
Resource Hash
69ae95b7f73e2899d0c398ed4fb9faba242bbec4d0a58b182e4dd0e7808f01ac

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/

Response headers

content-type
text/html
content-length
1044
date
Wed, 20 Oct 2021 07:15:05 GMT
accept-ranges
bytes
cache-control
max-age=31536000
content-encoding
br
etag
"63e08f928469ab67d9dac30c065ed182"
last-modified
Wed, 20 Oct 2021 07:15:01 GMT
x-amz-server-side-encryption
AES256
x-robots-tag
none
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 f7b7cf90592cf6a380fd34cc45e9c4b5.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Q53ONqgZcYkRX2jJ8t2CGtG_NfAFnE-ih9lSS8fZn7Srt0wvDYpaGQ==
age
1665922
visit-data
in.hotjar.com/api/v2/client/sites/677752/
146 B
323 B
XHR
General
Full URL
https://in.hotjar.com/api/v2/client/sites/677752/visit-data?sv=6
Requested by
Host: script.hotjar.com
URL: https://script.hotjar.com/modules.d4630e91cffbd6b56a37.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.254.124.164 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-254-124-164.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
1f93261e6db2c54e59dd3384dbb44d59a47c0118c3526bec3a3e5f52925e5243

Request headers

Referer
https://eyewire.news/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Content-Type
text/plain; charset=UTF-8

Response headers

date
Mon, 08 Nov 2021 14:00:28 GMT
content-encoding
br
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-max-age
86400
cache-control
no-cache, no-store
access-control-allow-credentials
true
koi
koi-3qnoybpdqq.marketingautomation.services/
148 B
606 B
Script
General
Full URL
https://koi-3qnoybpdqq.marketingautomation.services/koi?rf=&hn=eyewire.news&lg=en-US&sr=1600x1200&cd=24&vr=2.4.0&se=1636380028334&ac=KOI-4E14XPCYTK&ts=1636380028&pt=0&pl=0&loc=https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email&tp=page&ti=FDA%20Approves%20Allergan%27s%20Vuity%2C%20the%20First%20and%20Only%20Eye%20Drop%20to%20Treat%20Presbyopia%20-%20Eyewire%2B
Requested by
Host: koi-3qnoybpdqq.marketingautomation.services
URL: https://koi-3qnoybpdqq.marketingautomation.services/client/ss.js?ver=2.4.0
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
107.178.240.224 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
224.240.178.107.bc.googleusercontent.com
Software
openresty /
Resource Hash
79d053131f830713e749effca2f7b9c9879f7a2bca2ffaa6b45859cad3d63de8
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 08 Nov 2021 14:00:28 GMT
content-encoding
gzip
x-clacks-overhead
GNU Terry Pratchett
last-modified
Mon, 08 Nov 2021 14:00:28 GMT
server
openresty
vary
Accept-Encoding
p3p
CP='This is not a P3P policy! See https://sharpspring.com/legal/privacy/ for more info.'
via
1.1 google
cache-control
no-store, no-cache, must-revalidate, pre-check=0, post-check=0, max-age=0
pod-hostname
koi-7bc469d9d6-dsfnb
content-type
application/javascript
alt-svc
clear
x-xss-protection
1; mode=block
expires
Sat, 26 Jul 1997 05:00:00 GMT
6022f26150c92c727400009e.js
tag.perfectaudience.com/serve/
13 KB
4 KB
Script
General
Full URL
https://tag.perfectaudience.com/serve/6022f26150c92c727400009e.js
Requested by
Host: koi-3qnoybpdqq.marketingautomation.services
URL: https://koi-3qnoybpdqq.marketingautomation.services/client/ss.js?ver=2.4.0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.66.217 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Cowboy /
Resource Hash
35d3348f838b99abcbf8cdaf79b6b1df3e86c7aa63bb14c0a6a09b1283008aa5
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:28 GMT
via
1.1 vegur, 1.1 varnish
x-content-type-options
nosniff
server
Cowboy
age
360
x-served-by
cache-fra19146-FRA
vary
Accept-Encoding
x-cache
HIT
content-type
text/javascript
content-encoding
gzip
cache-control
max-age=1800
accept-ranges
bytes
x-timer
S1636380029.689424,VS0,VE1
content-length
4312
x-cache-hits
1
fbevents.js
connect.facebook.net/en_US/
98 KB
26 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: tag.perfectaudience.com
URL: https://tag.perfectaudience.com/serve/6022f26150c92c727400009e.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
b23807a4c5d90afca0dc47d688c0a05302779429dab75f5e6182562dcc2970f6
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600,h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
25965
x-xss-protection
0
pragma
public
x-fb-debug
I5+NHnD/nUVoSPf5j8K9tBYuW9MyXoYUbY763SbtOYjWT/HkqVc9S7LZpEg3pyWhNvTdO/EFkSA/htkuMfkAgA==
x-fb-trip-id
686109401
x-frame-options
DENY
date
Mon, 08 Nov 2021 14:00:28 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
expires
Sat, 01 Jan 2000 00:00:00 GMT
tagjs
pixel-geo.prfct.co/
Redirect Chain
  • https://pixel-geo.prfct.co/tagjs?a_id=159839&source=js_tag
  • https://pixel-geo.prfct.co/tagjs?check_cookie=1&a_id=159839&source=js_tag
136 B
465 B
Script
General
Full URL
https://pixel-geo.prfct.co/tagjs?check_cookie=1&a_id=159839&source=js_tag
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
34.250.84.130 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-250-84-130.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
afc5aa7e78310472b554b3a28b21563370f322911e372092dc3ebe0fe67da13e

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Cache-Control
no-store, no-cache, private
Connection
keep-alive
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Content-Length
136
Content-Type
text/javascript

Redirect headers

Location
https://pixel-geo.prfct.co/tagjs?check_cookie=1&a_id=159839&source=js_tag
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Length
0
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
496144884760121
connect.facebook.net/signals/config/
305 KB
87 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/496144884760121?v=2.9.48&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
1248726fa1e0274d86aa0c00f49b8f22342a3f69e1340062516e2d12d5d7f6e0
Security Headers
Name Value
Content-Security-Policy default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

content-security-policy
default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600,h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
x-xss-protection
0
pragma
public
x-fb-debug
eIufWu1nwwKKkX88xGAzlQlcBjryXRFke4No6KpLt/WZqzvFi/KDzWjrdAlbT9MnGejkriCvTAGd1++nIvum5g==
x-fb-trip-id
686109401
x-frame-options
DENY
cross-origin-opener-policy
same-origin-allow-popups
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
date
Mon, 08 Nov 2021 14:00:28 GMT
strict-transport-security
max-age=31536000; preload; includeSubDomains
report-to
{"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/?minimize=0"}],"group":"coep_report"}
content-type
application/x-javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=1200
x-fb-rlafr
0
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
44 B
313 B
Image
General
Full URL
https://www.facebook.com/tr/?id=496144884760121&ev=PageView&dl=https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email&rl=&if=false&ts=1636380028826&sw=1600&sh=1200&v=2.9.48&r=stable&ec=0&o=30&fbp=fb.1.1636380028823.1758365339&it=1636380028740&coo=false&exp=p0&rqm=GET
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:28 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600, h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Mon, 08 Nov 2021 14:00:28 GMT
/
pixel-geo.prfct.co/usermap/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://pixel-geo.prfct.co/usermap/?xid=$UID&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ
  • https://secure.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fpixel-geo.prfct.co%2Fusermap%2F%3Fxid%3D%24UID%26sid%3D202111%7C61892d7cb663f107323cd788%26pid%3Dpa_UGsQ1ydO4z3X3wPpJ
  • https://pixel-geo.prfct.co/usermap/?xid=4541810686184272198&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ
43 B
256 B
Image
General
Full URL
https://pixel-geo.prfct.co/usermap/?xid=4541810686184272198&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
34.250.84.130 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-250-84-130.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Cache-Control
no-store, no-cache, private
Connection
keep-alive
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Content-Length
43
Content-Type
image/gif

Redirect headers

Pragma
no-cache
Date
Mon, 08 Nov 2021 14:00:29 GMT
X-Proxy-Origin
168.119.25.193; 168.119.25.193; 728.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
b7fed17e-dd19-4b9a-9b74-11bf435f21ff
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://pixel-geo.prfct.co/usermap/?xid=4541810686184272198&sid=202111|61892d7cb663f107323cd788&pid=pa_UGsQ1ydO4z3X3wPpJ
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
adsct
analytics.twitter.com/i/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=twtr
  • https://analytics.twitter.com/i/adsct?p_id=48571&p_user_id=pa_UGsQ1ydO4z3X3wPpJ
43 B
598 B
Image
General
Full URL
https://analytics.twitter.com/i/adsct?p_id=48571&p_user_id=pa_UGsQ1ydO4z3X3wPpJ
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Server
104.244.42.131 , United States, ASN13414 (TWITTER, US),
Reverse DNS
Software
tsa_o /
Resource Hash
ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957
Security Headers
Name Value
Strict-Transport-Security max-age=631138519
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200 OK
x-twitter-response-tags
BouncerCompliant
content-length
65
x-xss-protection
0
x-response-time
111
pragma
no-cache
last-modified
Mon, 08 Nov 2021 14:00:29 GMT
server
tsa_o
x-frame-options
SAMEORIGIN
strict-transport-security
max-age=631138519
content-type
image/gif;charset=utf-8
cache-control
no-cache, no-store, must-revalidate, pre-check=0, post-check=0
x-connection-hash
428348eb220bb672aa1386e59276be5df864961395b35b940323fb311519454f
x-transaction
67c2b295f27a1bbe
expires
Tue, 31 Mar 1981 05:00:00 GMT

Redirect headers

Location
https://analytics.twitter.com/i/adsct?p_id=48571&p_user_id=pa_UGsQ1ydO4z3X3wPpJ
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Length
0
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
cb
pixel.prfct.co/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=crw
  • https://cw.addthis.com/t.gif?pid=37&pidt=0&pdid=pa_UGsQ1ydO4z3X3wPpJ&cu=https%3A%2F%2Fpixel.prfct.co%2Fcb%3FpartnerId%3Dcrw
  • https://pixel.prfct.co/cb?partnerId=crw
43 B
365 B
Image
General
Full URL
https://pixel.prfct.co/cb?partnerId=crw
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
54.242.174.54 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-242-174-54.compute-1.amazonaws.com
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Cache-Control
no-store, no-cache, private
Connection
keep-alive
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Content-Length
43
Content-Type
image/gif

Redirect headers

location
https://pixel.prfct.co/cb?partnerId=crw
pragma
no-cache
date
Mon, 08 Nov 2021 14:00:29 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
expires
Mon, 08 Nov 2021 14:00:29 GMT
sync
ups.analytics.yahoo.com/ups/58288/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=yah
  • https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1
  • https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1&verify=true
0
122 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1&verify=true
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Server
18.156.0.31 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:29 GMT
server
ATS/9.1.0.33
age
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/58288/sync?uid=pa_UGsQ1ydO4z3X3wPpJ&_origin=1&verify=true
date
Mon, 08 Nov 2021 14:00:29 GMT
server
ATS/9.1.0.33
age
0
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sd
us-u.openx.net/w/1.0/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=opx
  • https://us-u.openx.net/w/1.0/sd?id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ
  • https://us-u.openx.net/w/1.0/sd?cc=1&id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ
43 B
180 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?cc=1&id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Server
34.98.64.218 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/16.218.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 08 Nov 2021 14:00:29 GMT
via
1.1 google
server
OXGW/16.218.0
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
content-type
image/gif
alt-svc
clear
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://us-u.openx.net/w/1.0/sd?cc=1&id=537114372&val=pa_UGsQ1ydO4z3X3wPpJ
date
Mon, 08 Nov 2021 14:00:29 GMT
via
1.1 google
server
OXGW/16.218.0
alt-svc
clear
content-length
0
p3p
CP="CUR ADM OUR NOR STA NID"
tap.php
pixel.rubiconproject.com/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=rbcn
  • https://pixel.rubiconproject.com/tap.php?v=189868&nid=4106&expires=30&put=pa_UGsQ1ydO4z3X3wPpJ
0
239 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=189868&nid=4106&expires=30&put=pa_UGsQ1ydO4z3X3wPpJ
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
69.173.144.165 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
X-RPHost
8f052d4f888ae4e0626c5f819879cacd
Content-Type
image/gif

Redirect headers

Location
https://pixel.rubiconproject.com/tap.php?v=189868&nid=4106&expires=30&put=pa_UGsQ1ydO4z3X3wPpJ
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Length
0
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
cb
pixel-geo.prfct.co/
Redirect Chain
  • https://pixel-geo.prfct.co/cs/?partnerId=goo
  • https://cm.g.doubleclick.net/pixel?google_nid=nowspots_bidder&google_hm=cGFfVUdzUTF5ZE80ejNYM3dQcEo
  • https://pixel-geo.prfct.co/cb?partnerId=goo
43 B
365 B
Image
General
Full URL
https://pixel-geo.prfct.co/cb?partnerId=goo
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
34.250.84.130 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-250-84-130.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Cache-Control
no-store, no-cache, private
Connection
keep-alive
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Content-Length
43
Content-Type
image/gif

Redirect headers

pragma
no-cache
date
Mon, 08 Nov 2021 14:00:29 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://pixel-geo.prfct.co/cb?partnerId=goo
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
240
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
pixel-geo.prfct.co/seg/
43 B
365 B
Image
General
Full URL
https://pixel-geo.prfct.co/seg/?add=25477988,26756226&source=js_tag&a_id=159839
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.250.84.130 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-250-84-130.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Cache-Control
no-store, no-cache, private
Connection
keep-alive
P3P
CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Content-Length
43
Content-Type
image/gif
tr
www.facebook.com/
44 B
101 B
Image
General
Full URL
https://www.facebook.com/tr?id=496144884760121&ev=ViewContent&cd[rtb_id]=26756226&noscript=1
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:28 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600, h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Mon, 08 Nov 2021 14:00:28 GMT
bounce
secure.adnxs.com/
Redirect Chain
  • https://secure.adnxs.com/seg?t=2&add=26756226
  • https://secure.adnxs.com/bounce?%2Fseg%3Ft%3D2%26add%3D26756226
43 B
1023 B
Image
General
Full URL
https://secure.adnxs.com/bounce?%2Fseg%3Ft%3D2%26add%3D26756226
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Server
185.33.221.50 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 08 Nov 2021 14:00:29 GMT
X-Proxy-Origin
168.119.25.193; 168.119.25.193; 728.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
934288a5-7757-47d5-9550-c24438eb5842
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Mon, 08 Nov 2021 14:00:29 GMT
X-Proxy-Origin
168.119.25.193; 168.119.25.193; 728.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
5010d3c5-aa2f-4741-9205-81f071562a31
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://secure.adnxs.com/bounce?%2Fseg%3Ft%3D2%26add%3D26756226
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
tr
www.facebook.com/
44 B
101 B
Image
General
Full URL
https://www.facebook.com/tr?id=496144884760121&ev=ViewContent&cd[rtb_id]=25477988&noscript=1
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:28 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600, h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Mon, 08 Nov 2021 14:00:28 GMT
seg
secure.adnxs.com/
43 B
1023 B
Image
General
Full URL
https://secure.adnxs.com/seg?t=2&add=25477988
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.50 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
728.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 08 Nov 2021 14:00:29 GMT
X-Proxy-Origin
168.119.25.193; 168.119.25.193; 728.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
4adc31aa-7b8a-4371-946e-6bb7df1fb248
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
/
www.facebook.com/tr/
44 B
147 B
Image
General
Full URL
https://www.facebook.com/tr/?id=496144884760121&ev=Microdata&dl=https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email&rl=&if=false&ts=1636380029329&cd[DataLayer]=%5B%5D&cd[Meta]=%7B%22title%22%3A%22FDA%20Approves%20Allergan%27s%20Vuity%2C%20the%20First%20and%20Only%20Eye%20Drop%20to%20Treat%20Presbyopia%20-%20Eyewire%2B%22%2C%22meta%3Akeywords%22%3A%22Allergan%2C%20Presbyopia%2C%20Vuity%2C%20Glaucoma%2C%20Cataract%2C%20Health%20Care%2C%20Optometry%2C%20Product%20Approval%2C%20Retina%2C%20Cornea%2C%20Refractive%2C%20Ophthalmology%2C%20Allergan%22%2C%22meta%3Adescription%22%3A%22Allergan%20announced%20the%20FDA%26nbsp%3Bapproval%20of%20Vuity%20(pilocarpine%20HCl%20ophthalmic%20solution)%201.25%25%26nbsp%3Bfor%20the%20treatment%20of%20presbyopia%26nbsp%3Bin%20adults.%20Vui%22%7D&cd[OpenGraph]=%7B%22og%3Aurl%22%3A%22https%3A%2F%2Feyewire.news%2Fnews%2Ffda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%22%2C%22og%3Atype%22%3A%22website%22%2C%22og%3Asite_name%22%3A%22Eyewire%2B%22%2C%22og%3Atitle%22%3A%22FDA%20Approves%20Allergan%27s%20Vuity%2C%20the%20First%20and%20Only%20Eye%20Drop%20to%20Treat%20Presbyopia%20-%20Eyewire%2B%22%2C%22og%3Adescription%22%3A%22Allergan%20announced%20the%20FDA%26nbsp%3Bapproval%20of%20Vuity%20(pilocarpine%20HCl%20ophthalmic%20solution)%201.25%25%26nbsp%3Bfor%20the%20treatment%20of%20presbyopia%26nbsp%3Bin%20adults.%20Vui%22%2C%22og%3Aimage%22%3A%22https%3A%2F%2Fcore4.bmctoday.net%2Fstorage%2Fimages%2F11597815c35_R0_SmAngledBox_Bottle_1635604021.jpg%3Fv%3D%22%7D&cd[Schema.org]=%5B%5D&cd[JSON-LD]=%5B%5D&sw=1600&sh=1200&v=2.9.48&r=stable&ec=1&o=30&fbp=fb.1.1636380028823.1758365339&it=1636380028740&coo=false&es=automatic&tm=3&exp=p0&rqm=GET
Requested by
Host: eyewire.news
URL: https://eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia?utm_campaign=Enewsletters&utm_medium=email&_hsmi=179372714&_hsenc=p2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag&utm_content=179372714&utm_source=hs_email
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://eyewire.news/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36

Response headers

date
Mon, 08 Nov 2021 14:00:29 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=3600, h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Mon, 08 Nov 2021 14:00:29 GMT
v2iut3vZEdu--EQjXHGJk9kfNqomakGJRfVHhyeRLh-tZ1p3BA66oJRj6LzR8e9eJ0oA273kuhLjOYWEXIUk
scaredsidewalk.com/
216 B
611 B
Fetch
General
Full URL
https://scaredsidewalk.com/v2iut3vZEdu--EQjXHGJk9kfNqomakGJRfVHhyeRLh-tZ1p3BA66oJRj6LzR8e9eJ0oA273kuhLjOYWEXIUk
Requested by
Host: scaredsidewalk.com
URL: https://scaredsidewalk.com/v2yzgyC3XvHkuj_di8jp-6Su0yVIVtrebnqdUhIXMYKmrbLPMFJ6pTxmDmUrPxMWqJA
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.103.212 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
212.103.201.35.bc.googleusercontent.com
Software
/
Resource Hash
3193299287e45f15ea6ff06a40fcc725f5f2785b48a7ecf02271a2e5e4e48751
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; preload

Request headers

Referer
https://eyewire.news/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15724800; preload
x-datacenter
gce-europe-west1
date
Mon, 08 Nov 2021 14:00:33 GMT
vary
Accept-Encoding, Origin
access-control-allow-methods
POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
https://eyewire.news
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-hostname
0f8346e1
timing-allow-origin
*
access-control-allow-headers
DNT,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Cookie
content-length
216
expires
Mon, 08 Nov 2021 14:00:32 GMT
v2mizr31t5XltgBnC6LKoCC-94K62Eh-bu_45JIZ0EU4_xe5WVQECHG9oU5aJaHKvqcx5symETD6K7nLShR8
scaredsidewalk.com/
3 B
36 B
Fetch
General
Full URL
https://scaredsidewalk.com/v2mizr31t5XltgBnC6LKoCC-94K62Eh-bu_45JIZ0EU4_xe5WVQECHG9oU5aJaHKvqcx5symETD6K7nLShR8
Requested by
Host: scaredsidewalk.com
URL: https://scaredsidewalk.com/v2yzgyC3XvHkuj_di8jp-6Su0yVIVtrebnqdUhIXMYKmrbLPMFJ6pTxmDmUrPxMWqJA
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.103.212 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
212.103.201.35.bc.googleusercontent.com
Software
/
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; preload

Request headers

Referer
https://eyewire.news/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/95.0.4638.54 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15724800; preload
x-datacenter
gce-europe-west1
date
Mon, 08 Nov 2021 14:00:33 GMT
vary
Accept-Encoding, Origin
access-control-allow-methods
POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
https://eyewire.news
access-control-allow-credentials
true
x-hostname
0f8346e1
timing-allow-origin
*
access-control-allow-headers
DNT,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Cookie
content-length
3

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
bmcanalytics.piwik.pro
URL
https://bmcanalytics.piwik.pro/audiences/static/widget/audience-manager.api.min.js
Domain
bmcanalytics.containers.piwik.pro
URL
https://bmcanalytics.containers.piwik.pro/3aa8057d-9500-485f-a9f4-c346e81304ac.js

Verdicts & Comments Add Verdict or Comment

64 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| onbeforexrselect function| reportError boolean| originAgentCluster object| scheduler boolean| adblock object| googletag number| windowWidth function| gtag object| dataLayer object| _hsq function| hj object| _hjSettings function| admiral object| ppms function| $ function| jQuery function| LazyLoad object| html5 object| Modernizr function| yepnope object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| ggeac object| google_js_reporting_queue object| google_tag_manager object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled object| hjLazyModules object| _paq function| sanitizeKey boolean| _hstc_loaded object| google_tag_data string| GoogleAnalyticsObject function| ga function| Cookies function| tinysort object| recaptcha undefined| google_measure_js_timing object| googleToken object| googleIMState function| processGoogleToken number| google_unique_id object| gaGlobal object| gaplugins object| gaData function| setUrl object| Core4 function| copyToClipboard object| _ss object| _pa function| 4dm1r11545242527 boolean| sharpspring_tracking_installed boolean| loadedBool function| facebookEventsHelper function| googleAdsEventsHelper function| fbq function| _fbq object| _pq string| curViewport

32 Cookies

Domain/Path Name / Value
eyewire.news/ Name: eyewire_plus_session
Value: GcR3EvSJLAXvyyNQG7w14ZXO0zyA18PCvM1yM9aj
.eyewire.news/ Name: _hjid
Value: 2ecec2dd-74c6-4141-8bfe-ef7c933e3fec
.eyewire.news/ Name: _hjFirstSeen
Value: 1
.eyewire.news/ Name: _ga
Value: GA1.2.1452769361.1636380028
.eyewire.news/ Name: _gid
Value: GA1.2.221109256.1636380028
.eyewire.news/ Name: _gat_gtag_UA_11843436_1
Value: 1
.eyewire.news/ Name: __gads
Value: ID=28abe8461dc5b757-22fa38193acb00d7:T=1636380027:S=ALNI_MZjRNJoyWDO_8tvQjiLVTwmaX845g
eyewire.news/ Name: _hjIncludedInPageviewSample
Value: 1
.eyewire.news/ Name: _hjAbsoluteSessionInProgress
Value: 0
eyewire.news/ Name: _hjIncludedInSessionSample
Value: 1
eyewire.news/ Name: __ss
Value: 1636380028334
eyewire.news/ Name: __ss_referrer
Value: https%3A//eyewire.news/news/fda-approves-allergans-vuity-the-first-and-only-eye-drop-to-treat-presbyopia%3Futm_campaign%3DEnewsletters%26utm_medium%3Demail%26_hsmi%3D179372714%26_hsenc%3Dp2ANqtz-8fMB2_YtkGtqjRBdkJECo7L1usFo0azXO9tT4crBq7b5gOgQHq7I2Sa1YZaKnZf_PJdo3DAijL3CiAfydg9Rk4ar-eag%26utm_content%3D179372714%26utm_source%3Dhs_email
.marketingautomation.services/ Name: koitk
Value: 202111%7C61892d7cb663f107323cd788
eyewire.news/ Name: __ss_tk
Value: 202111%7C61892d7cb663f107323cd788
.eyewire.news/ Name: _fbp
Value: fb.1.1636380028823.1758365339
.prfct.co/ Name: pa_uid
Value: pa_UGsQ1ydO4z3X3wPpJ
.prfct.co/ Name: pa_twitter_ts
Value: 1636380028955
.prfct.co/ Name: pa_crosswise_ts
Value: 1636380028988
.adnxs.com/ Name: uuid2
Value: 4541810686184272198
.prfct.co/ Name: pa_yahoo_ts
Value: 1636380029011
.prfct.co/ Name: pa_openx_ts
Value: 1636380029011
.prfct.co/ Name: pa_rubicon_ts
Value: 1636380029013
.prfct.co/ Name: pa_google_ts
Value: 1636380029018
.yahoo.com/ Name: A3
Value: d=AQABBH0tiWECEIGxPPnz5xcsvOaTksmDIigFEgEBAQF-imGTYQAAAAAA_eMAAA&S=AQAAAnUx9f7IUIASo5W_2sctDgw
.openx.net/ Name: i
Value: 4b791957-e89b-44f5-94dc-71601e747892|1636380029
.analytics.yahoo.com/ Name: IDSYNC
Value: 18z4~21f1
.doubleclick.net/ Name: IDE
Value: AHWqTUm1Btl6eE90HvkYz-IOHyndRkxxkv4DO8vMFk3Bs-obO6e1Vrdixay_TGNY1Nk
.adnxs.com/ Name: anj
Value: dTM7k!M4/8D>6NRF']wIg2IlhqhG$/!fss0=Ir4A3KL9D3I?-x=JQ4/
.twitter.com/ Name: personalization_id
Value: "v1_WWPHVW7bBLfXw2XRfadaRA=="
.addthis.com/ Name: ouid
Value: 61892d7d000173e6427938ed9d8c1060d9105bee36322999a5a3
.addthis.com/ Name: uid
Value: 61892d7d1c8ffeee
.addthis.com/ Name: na_id
Value: 2021110814002916100575861701

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

0c7ae8d76b6d2d33de89508fd26c900a.safeframe.googlesyndication.com
adservice.google.com
adservice.google.de
analytics.twitter.com
bmcanalytics.containers.piwik.pro
bmcanalytics.piwik.pro
cdnjs.cloudflare.com
cm.g.doubleclick.net
connect.facebook.net
core4.bmctoday.net
cw.addthis.com
eyewire.news
in.hotjar.com
js.hs-analytics.net
koi-3qnoybpdqq.marketingautomation.services
p.typekit.net
pixel-geo.prfct.co
pixel.prfct.co
pixel.rubiconproject.com
scaredsidewalk.com
script.hotjar.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.adsafeprotected.com
static.hotjar.com
stats.g.doubleclick.net
tag.perfectaudience.com
ups.analytics.yahoo.com
us-u.openx.net
use.typekit.net
vars.hotjar.com
www.facebook.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.googletagservices.com
www.gstatic.com
bmcanalytics.containers.piwik.pro
bmcanalytics.piwik.pro
104.244.42.131
104.75.88.126
107.178.240.224
142.250.181.226
142.250.186.130
143.204.98.29
143.204.98.32
143.204.98.33
151.101.66.217
18.156.0.31
185.33.221.50
2600:9000:2156:fa00:8:48e:53c0:93a1
2606:4700::6810:135e
2606:4700::6811:45b0
2a00:1450:4001:810::2002
2a00:1450:4001:811::2002
2a00:1450:4001:82a::2003
2a00:1450:4001:82a::2004
2a00:1450:4001:82a::2008
2a00:1450:4001:82b::2001
2a00:1450:4001:82b::200e
2a00:1450:400c:c03::9c
2a02:26f0:6c00:28d::19fd
2a02:26f0:6c00::210:ba0a
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
3.220.15.29
34.250.84.130
34.254.124.164
34.98.64.218
35.201.103.212
52.0.44.193
54.242.174.54
69.173.144.165
00045ced31b0162f718bb52d24da80957ee91ceea8ef42b770f553f04889ec7f
0059cb4ff0a271382c38af8a7367aaf45cbeb31449637d3928d25317401e2828
0b2a741489fb323cd96e2b546693ca1fc7151cfa0f2111eee4dd512e6b359941
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
1248726fa1e0274d86aa0c00f49b8f22342a3f69e1340062516e2d12d5d7f6e0
12ccf827ffd5452b891e6219a9d3be8222aea9ab9d2277bfb9cf06e745dc2159
1a6aa1721fd3fbd15c8b690d917e5cce3c49face35cdfbc33c3b9364453e11a7
1b134d750801cede012084b0fe5384264f95aec96b9be9dbf5cf7a42dff81117
1c0ff118a4290c99f39c90abb38703a866e47251b23cca20266c69c812ccafeb
1f93261e6db2c54e59dd3384dbb44d59a47c0118c3526bec3a3e5f52925e5243
286ced3f47dcdcc61920c6cad37d2168b92c4edd9a47eb0b647d998fa5cfe201
3193299287e45f15ea6ff06a40fcc725f5f2785b48a7ecf02271a2e5e4e48751
3202ba1cb0ab2ebf8eeb0caebf6fa6ba681b5575c48b2f314f345d82eedaaac2
35d3348f838b99abcbf8cdaf79b6b1df3e86c7aa63bb14c0a6a09b1283008aa5
42b976597a2d977d0e300f6d06bc903db389e5c112d33c1c8c249690a522d9f2
458c60eed8899cb810aba300f7b68f3b2f900add77eb41b93ec0a6897c3cedd0
4a8b1688e8561642448dee7970e986fc086115d5fcda360c0ba44c14e030422e
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
4c0cc637858d6503cba9262f8be75740c29e853605a153a7bde46a6e2e367eb0
4d17c46f372f4e8422d6beba41042db9a7211562d921fb16c0a2c663e7e6891e
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
50ad3a273dd7803066fae0fb2e4eec57cdfb969f449d86309527578d7e08d249
519f71e8a6cac156c0290fb5b79372191890e23d46a94cbe3a744e6470f074c1
5736e3eec0c34bfc288854b7b8d2a8f1e22e9e2e7dae3c8d1ad5dfb2d4734ad0
5e245c78f13d392d81ed85a0fbe2518c45ab6d34839856aea4bf2c7402b05994
5efc5dfd683b93e41cf5c563bd121060d7d6e79fb85cea91fdcdd2390fbd870f
5fccf4b8b64dec989d6295cf25e3af5dbc7a5ba965875ff07f0eff9c98ed4def
6293352639977ab51c2987a9bea83dd580c3d61f69c82900193971aa2441ed71
633a5afd1cc1ff46c78c44457e92969f185435e741a304ed822e63101ab7b142
69ae95b7f73e2899d0c398ed4fb9faba242bbec4d0a58b182e4dd0e7808f01ac
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
6dc1785f7aee2d82fc98964068452483b6d76c5f2e1671081a0ebc5b88df7558
79d053131f830713e749effca2f7b9c9879f7a2bca2ffaa6b45859cad3d63de8
84fb2b6f8ec189ce3220b7cca5f41270ef74ad294fc0f5267b57c32dcda90001
8c78a51baaafdb60084333cabd9099b2f37278adf882cea7d5de0ef1188c5aa6
8c8bd8d99b05c8348e32644b8e25cc70efce41c396b5958727178611856c6c2c
9b80d81bcdcba7b6f787cad8c103d520eb4b68ce9299abd52195c99f6c100900
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7
a366cc8c38cafb91d8cf5036bef52832d397236001bcefcbb214b25fbeed4425
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957
afc5aa7e78310472b554b3a28b21563370f322911e372092dc3ebe0fe67da13e
b0df3444c55338c1de6e7e21c438a8073dc196273914d39958c2a43ce73ee45c
b23807a4c5d90afca0dc47d688c0a05302779429dab75f5e6182562dcc2970f6
b39b617c63e4f29f1a677c2f350c3c9b14ac8455d721c26b90eb034a0933e00f
b69dcd0486530c313a1771d1d922ca2834ea0c43a06c7da87ed26937c80b2883
c25b5762336d9578b4e7497e5688ceae44a63b30bfa77a9ea03cce10ed2e912e
c94b350d90e850fefdbfc5d9498770dac371f18876191821eec42c0bfc69484d
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
cadda460ccb4c3c01bb45f3d5976f63f5adf8dc3ff1d31cb4fbd3ded4f18e5bf
d35c881fea16d4971f529ebb5690448817d1ccb91d394890298e81e5c50858a5
d75dfc1b59df3c317def1bc9c540072146ed8f177f18303f9f20af5fdc733bad
d99ad77f8f1e1522b88c21422bfb4f602e10d5e0f820e7774ff4f80add7f432a
dc910bfbe23f33ed76920d826ef313c59e9dec1cea0d41cc899448231da5ae91
dd8bce41d0be6d4e5449bef910b493bcf872a4189a361451102996bfe0082f3a
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e6a23e6a3399b52a5576c28b2236b48953949793fc17f2c733d35b084d7a0085
e9002760a6df7b501d46f07c7d78968e079bed312d00469585eb0a52b062c5f3
f02754021c8618177ed0b2b5926c7015e0f30f5efb97924bb08a6ad6dba97fb2
f0734491d9e30ab4f2fd976ba4cda6ba071154f24ea8fcd53147618d03338453
f1e058418cedc72dc4488f8d4d13a6a385f2b4c1c2d92348106065c884aa0afd
f1e84c405eccf9a1d2ebd78fce644908057170b525733a83e326fc27893ff7c1
f4dafc81e4277ff73cf3d15c1efa531d0e7c21e26f2ebedc479ac68633647775
f706548f1b92012cc9c1973b2974b0577f91e8d42befd50b570dbe1ae1f2dec7
fd222137f245c06ddb4c4d44db41f12138dad6cf8ef5d4d4a5e500f38f0c8c62
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e